HOME >> MEDICINE >> NEWS
Commonly recommended sedative does not improve infant sleep

An antihistamine often recommended to parents whose infants do not sleep through the night may not be effective in reducing nighttime awakenings or improving parents' happiness with their children's sleep, according to a report in the July issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

Between 20 and 46 percent of parents have reported that their infants have trouble sleeping, according to background information in the article. Some parents let their children cry for extended periods at night--this method, known as crying out, is popular but controversial among parents and health care professionals. Another commonly used method is to give children medications--such as antihistamines, normally used to treat allergies--to sedate them at bedtime. Diphenhydramine hydrochloride, sold as Benadryl, is often used by parents and recommended by physicians despite the fact that it has not been studied in children younger than age 2 years.

Dan Merenstein, M.D., then at The Johns Hopkins School of Medicine, Baltimore, and now at Georgetown University, Washington, D.C., and colleagues conducted a trial of diphenhydramine in 44 children ages 6 to 15 months who slept in cribs. Parents in the study had all reported that their children woke up two or more times per night. The participating infants were randomly assigned to receive 100 mL of diphenhydramine or placebo (inactive medication) in a cherry-flavored liquid 30 minutes before bedtime for one week between May 2004 and May 2005. Parents reported whether the child had fewer awakenings that required parental intervention during that week and also tracked their child's sleep in a diary for the first 28 days. At four points during the first 43 days of the study, parents were asked to rate their happiness with their children's sleep on a scale of one to 10.

Three of 22 participants in the placebo group and one of 22 participants in the dip
'"/>

Contact: Liz McDonald
202-687-5100
JAMA and Archives Journals
3-Jul-2006


Page: 1 2

Related medicine news :

1. Commonly used drug offers promise for premature babies
2. Commonly used pain medications do not prevent Alzheimers disease
3. Commonly used blood pressure medication prevents aortic aneurysm in mice with Marfan syndrome
4. Commonly used drug may prevent fetal alcohol syndrome
5. Commonly used antidepressants may also affect human immune system
6. Should adult male circumcision be recommended for HIV prevention in the US?
7. Medicaid patients less likely than those with private insurance to receive recommended cardiac care
8. Updated sleep apnea screening recommended for commercial drivers
9. Study provides evidence supporting recommended 10 year interval for colonoscopies for most patients
10. Many breast cancer survivors not getting recommended mammograms
11. Older patients with acute coronary syndromes not getting recommended treatment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Commonly recommended sedative does not improve infant sleep

(Date:3/31/2015)... SACRAMENTO, Calif. (PRWEB) March 31, 2015 ... important distinction between mice and humans: how human ... called PPARa, which activates liver regeneration. Normally, mouse ... the human form, allowing mice to quickly regenerate ... fibroblast growth factor 21 (FGF21) can boost the ...
(Date:3/31/2015)... Former 49ers linebacker Chris Borland turned more heads ... of a promising NFL career. In a March episode of ... Will Leitch explores the curious case of Borland and ... decision making process that Borland and other football players will ... large paycheck, and what impact, if any, he thinks this ...
(Date:3/31/2015)... March 31, 2015 National Adaptive ... social and psychological benefits of participating in adaptive ... of adaptive sports athletes that adapt, believe and ... support for inclusive fitness and inclusive athletics in ... participating in adaptive sports and advocate for an ...
(Date:3/31/2015)... NY (PRWEB) March 31, 2015 ... announce the presentation of new clinical study results ... arginine silicate (ASI), titled, “Arginine Silicate Supplementation Decreases ... Increases Markers of Vasodilation and Cardiovascular Health in ... scientists and other professionals at the acclaimed Experimental ...
(Date:3/31/2015)... 2015 The New Jersey Chapter ... (ACHCA) elected two administrators from Windsor Healthcare Communities, ... in New Jersey, to two key leadership roles ... Robert Reyes, administrator for Abingdon Care & Rehabilitation ... Yael Herman, administrator of Canterbury Care & Rehabilitation ...
Breaking Medicine News(10 mins):Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 3Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 4Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3Health News:April is National Adaptive Sports Month 2Health News:April is National Adaptive Sports Month 3Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 2Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 3Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 4Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 5Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 6Health News:Abingdon Care & Rehabilitation Center’s Administrator Elected President of N.J. Chapter of the American College of Health Care Administrators 2
(Date:3/31/2015)... , March 31, 2015   Halyard Health ... today announced it was awarded a new purchasing agreement ... face masks. Effective March 1, 2015, Halyard,s standard and ... SO SOFT* lining, will be available to HealthTrust members ... as 15,000 ambulatory surgery centers, physician practices and alternate ...
(Date:3/31/2015)... VICTORIA, BC , March 31, 2015 /CNW/ - T-Bird ... company focused on developing premium quality medical marijuana products ... the Marihuana for Medical Purposes Regulations ( Canada ... has received notice from The Corporation of the District ... rezoning approval of the Company,s premises which now allows ...
(Date:3/31/2015)... TEL AVIV, Israel, March 31, 2015  Galmed ... clinical-stage biopharmaceutical company focused on the development and ... treatment of liver diseases and cholesterol gallstones, today ... December 31, 2014. Fourth Quarter 2014 ... event featuring a keynote address by Professor Rohit ...
Breaking Medicine Technology:Halyard Health Signs First GPO Contracts As Independent Company 2Halyard Health Signs First GPO Contracts As Independent Company 3T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 2Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 3Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 4Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 5Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 6Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 7Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 8
Cached News: